Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2021
TaiMed Biologics announces tender offer for up to 30% of Hocang Biotechnology
TaiMed Biologics announced a tender offer for Hocang Biotechnology shares, seeking to acquire between 5% and approximately 30% of Hocang's issued shares. The offer period was announced as March 10 through April 16, 2021; the acquisition was proposed and not reported as completed.